5-(saenta-x8)fluorescein has been researched along with Multiple Myeloma in 1 studies
*Multiple Myeloma: A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brown, RD; Gibson, J; Jamieson, GP; Joshua, DE; Paterson, AR; Petersen, AJ; Pope, BB; Wiley, JS | 1 |
1 other study(ies) available for 5-(saenta-x8)fluorescein and Multiple Myeloma
| Article | Year |
|---|---|
Multiple myeloma: expression of nucleoside transporters on malignant plasma cells and their relationship to cellular proliferation.
Topics: ADP-ribosyl Cyclase; ADP-ribosyl Cyclase 1; Antibodies, Monoclonal; Antigens, CD; Antigens, Differentiation; Biomarkers, Tumor; Blood Proteins; Bone Marrow Cells; Carrier Proteins; Cell Division; Fluoresceins; Humans; Immunoglobulin A; Immunoglobulin G; Immunotoxins; Membrane Glycoproteins; Membrane Proteins; Multiple Myeloma; Nucleoside Transport Proteins; Phycoerythrin; Plasma Cells; Purine Nucleosides | 1994 |